Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;19(5):18.
doi: 10.1007/s11894-017-0557-x.

Antidiarrheal Drug Therapy

Affiliations
Review

Antidiarrheal Drug Therapy

Lawrence R Schiller. Curr Gastroenterol Rep. 2017 May.

Abstract

Introduction: Acute diarrhea often runs a self-limited course and little by way of treatment is needed except for oral rehydration therapy. Chronic diarrhea poses a longer-term problem. If not treatable with specific therapy aimed at the underlying pathophysiology, chronic diarrhea often needs long-term symptomatic therapy.

Purpose of review: This paper aims to examine the options for symptomatic, nonspecific treatment of diarrhea.

Recent findings: The most frequently used therapies are opiate antidiarrheal drugs. These drugs are effective for a wide variety of diarrheal conditions and generally can be used safely if monitored closely. They work by slowing motility and allowing more time for absorption. They vary in potency and in addictive liability. In recent years, a variety of other drugs have been developed, which provide more targeted therapy that can mitigate diarrhea in specific situations. These drugs work on other regulatory pathways in the gut or on mucosal absorptive mechanisms. There is evidence for efficacy for both traditional and newer agents used for the symptomatic management of diarrhea. Opiates are used most often for this indication. Other agents may benefit individuals, but further research is needed to establish indications and best practices.

Keywords: Acute diarrhea; Antidiarrheal drug; Chronic diarrhea; Gastrointestinal disorders.

PubMed Disclaimer

Similar articles

Cited by

References

    1. JPEN J Parenter Enteral Nutr. 2017 Aug;41(6):946-951 - PubMed
    1. Aliment Pharmacol Ther. 2015 Mar;41(5):438-48 - PubMed
    1. Gastroenterology. 1982 Jun;82(6):1335-40 - PubMed
    1. Clin Infect Dis. 2008 Oct 15;47(8):1007-14 - PubMed
    1. Clin Infect Dis. 2009 Mar 1;48(5):598-605 - PubMed

MeSH terms

LinkOut - more resources